NLRP3 inflammasome contributes through gut microbiota to control the NAFLD/obesity progression via overproduction of leptin, downregulation of adiponectin generation, and promotion of fibrosis [101]. This evidence concerns the gene LEP and metabolic dysfunction-associated steatotic liver disease.